Core capabilities in infectious disease and cancer diagnostics
A CAP-accredited and CLIA-certified laboratory, Pathnostics drives forward patient care with a range of unique and advanced tests — a robust offering of histopathology, cytology, and molecular tests across urology, women’s health, and gastroenterology.
Pathnostics believes in robust science to demonstrate safety, efficacy, and clinical utility. To date, we have completed eight clinical studies involving more than 73,000 subjects for Guidance® UTI — our flagship platform that combines molecular detection with our proprietary Pooled Antibiotic Susceptibility Testing (P-AST™) technology. Key findings are published in fifteen peer-reviewed journals.